Oncology News

ESMO oncology news ensures that you're always kept up to date with the latest developments that affect you and your daily practice. Make sure you check these pages frequently, or sign up to our newsletter.

Filter

Date Title Topic
12 Apr 2018 ELCC 2018 News: Second-line TKI Therapy Demonstrates Clinical Benefit in Patients with EGFR Mutated NSCLC and Leptomeningeal Metastasis Lung and other thoracic tumours - Personalised medicine - Anticancer agents & Biologic therapy
12 Apr 2018 ELCC 2018 News: Patients with Advanced Lung Adenocarcinoma and Complex EGFR Mutations Demonstrate Different Response Rates to TKI Therapy Lung and other thoracic tumours - Personalised medicine - Anticancer agents & Biologic therapy
11 Apr 2018 The PanCancer Atlas Completed Personalised medicine
10 Apr 2018 FDA Approves Rucaparib for Maintenance Treatment of Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Gynaecologic malignancies - Personalised medicine - Anticancer agents & Biologic therapy
09 Apr 2018 Withdrawal of Application for a Change to the Marketing Authorisation for Aranesp (Darbepoetin Alfa) Haematologic malignancies - Palliative and supportive care
06 Apr 2018 Generic Medicine Pemetrexed Krka Received a Positive Opinion from the EMA Lung and other thoracic tumours - Anticancer agents & Biologic therapy
05 Apr 2018 Bioinformatics for Precision Cancer Medicine Personalised medicine
04 Apr 2018 EMA Recommends Granting a Marketing Authorisation for a Biosimilar Trastuzumab (Kanjinti) Breast cancer - Gastrointestinal cancers - Anticancer agents & Biologic therapy
03 Apr 2018 Increased Levels of Screening for Symptoms of Metabolic Syndrome Called for in Testicular Cancer Survivors Genitourinary cancers
30 Mar 2018 EMA Recommends Extension of Therapeutic Indications for Fosaprepitant Palliative and supportive care
30 Mar 2018 FDA Grants Accelerated Approval to Blinatumomab for the Treatment of B-cell Precursor ALL Haematologic malignancies - Cancer Immunology and Immunotherapy
29 Mar 2018 Insufficient Evidence of Clinical Validity and Utility for the Majority of ctDNA Assays in Advanced Cancer Translational research - Personalised medicine
28 Mar 2018 FDA Approves Nilotinib for Paediatric Patients with Newly Diagnosed or Resistant/Intolerant Ph-Positive CML in Chronic Phase Haematologic malignancies - Anticancer agents & Biologic therapy
27 Mar 2018 EMA Recommends Extensions of Indications for Cabozantinib Genitourinary cancers - Anticancer agents & Biologic therapy
26 Mar 2018 EMA Recommends Granting a Conditional Marketing Authorisation for Rucaparib Gynaecologic malignancies - Anticancer agents & Biologic therapy